Quantitative study of the non-circularity of myelinated peripheral nerve fibres in the cat

The Journal of Physiology
E R ArbuthnottK U Kalu

Abstract

1. One hind limb of each of four cats was either chronically de-efferentated, or chronically de-afferentated, and perfused with buffered glutaraldehyde fixative. Up to three different muscle nerves were dissected from each limb, post-fixed in osmium tetroxide and embedded in Epon. Ultrathin transverse sections were mounted on Formvar-coated single-hole specimen grids so that all the fibres in each nerve could be examined individually by electron microscopy.2. Non-circularity was expressed as the ratio (ø): [Formula: see text] The degree of non-circularity of all the afferent axons, or all the efferent axons, in each muscle nerve was determined. The proportion of fibres cut through the paranodal region, or through the Schwann cell nucleus, was as expected for group I afferent and for alpha and gamma efferent fibres, but hardly any typical paranodal sections of group II or III afferent fibres were encountered which suggests that their paranodal arrangement differs from that of other groups. In a quantitative comparison of noncircularity in different functional groups, fibres cut through paranodes, Schwann cell nuclei or Schmidt-Lanterman clefts were rejected.3. All the gamma efferent fibres in one nerve were studied in a series o...Continue Reading

Citations

Jan 1, 1990·Acta Neuropathologica·G N FullerR J Guiloff
Jun 15, 1999·Brain Research. Molecular Brain Research·T W Abel, N E Rance
Feb 1, 1988·Journal of Neurocytology·R L PriceM J Katz
Jan 1, 1987·Anatomy and Embryology·I Fahrenkamp, R L Friede
Jul 19, 2008·Clinical Biomechanics·Jeremy P M Mogk, Peter J Keir
Feb 5, 2009·Journal of the Peripheral Nervous System : JPNS·Haruki HigashimoriRichard C Carlsen
Jun 18, 2011·The Journal of Comparative Neurology·Trygve E Bakken, Charles F Stevens
Jan 15, 2014·Journal of Veterinary Internal Medicine·H C SchenkA Tipold
Nov 1, 1985·Experimental Neurology·R L FriedeG Wegener
May 1, 1985·Experimental Neurology·H R Koerber, K W Horch
Nov 1, 1986·Neuropathology and Applied Neurobiology·S E MackinnonD A Hunter
Feb 1, 1996·Neurologic Clinics·J W GriffinD R Cornblath
Mar 13, 2014·The Journal of Steroid Biochemistry and Molecular Biology·Nico MitroRoberto Cosimo Melcangi
Sep 3, 2009·Journal of Neuroscience Methods·Rahul KasukurthiDaniel A Hunter
Dec 1, 1991·The Journal of Comparative Neurology·L AlfeiA Stefanelli
Jan 10, 2018·Frontiers in Neuroanatomy·Ariane SalianiJulien Cohen-Adad
Mar 22, 2005·Muscle & Nerve·Haruki HigashimoriRichard C Carlsen
Sep 1, 1993·Journal of Neurosurgery·A S DubuissonS S Weinshel
May 21, 2021·Scientific Reports·Ana G Hernandez-ReynosoMario I Romero-Ortega
Mar 11, 1982·Brain Research·R L Friede, R Bischhausen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.